We are working tirelessly to bring the best ideas forward.
BrainChild Bio is a kids-first, clinical-stage biotechnology company harnessing the power of CAR-T cell technology for tumors in the central nervous system (CNS), prioritizing pediatrics with plans to expand our technology platform to adult indications.
“BrainChild Bio will push the bounds of scientific discovery in service of children with cancer. For far too long, children have been deprioritized for commercialized medicines, and families have been left with few options.”
Michael Jensen, MD, Founder, Chief Scientific Officer